Cargando…
Treating Rett syndrome: from mouse models to human therapies
Rare diseases are very difficult to study mechanistically and to develop therapies for because of the scarcity of patients. Here, the rare neuro-metabolic disorder Rett syndrome (RTT) is discussed as a prototype for precision medicine, demonstrating how mouse models have led to an understanding of t...
Autores principales: | Vashi, Neeti, Justice, Monica J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606665/ https://www.ncbi.nlm.nih.gov/pubmed/30820643 http://dx.doi.org/10.1007/s00335-019-09793-5 |
Ejemplares similares
-
Aberrant lung lipids cause respiratory impairment in a Mecp2-deficient mouse model of Rett syndrome
por: Vashi, Neeti, et al.
Publicado: (2021) -
Rett syndrome: a neurological disorder with metabolic components
por: Kyle, Stephanie M., et al.
Publicado: (2018) -
Neuroanatomy in mouse models of Rett syndrome is related to the severity of Mecp2 mutation and behavioral phenotypes
por: Allemang-Grand, Rylan, et al.
Publicado: (2017) -
A suppressor screen in mouse Mecp2 implicates cholesterol metabolism in Rett Syndrome
por: Buchovecky, Christie M., et al.
Publicado: (2013) -
Alterations in the carnitine cycle in a mouse model of Rett syndrome
por: Mucerino, Sabrina, et al.
Publicado: (2017)